Conneqt Health Ltd (ASX:CQT) Share Price & Analysis

CONNEQT Health Limited (ASX: CQT), formerly known as CardieX Limited, is an Australian health technology company headquartered in Sydney, Australia. Listed on the Australian Securities Exchange under the ticker CQT, the company specializes in the design, development, and commercialization of noninvasive patient monitoring devices and advanced vascular biometrics for cardiovascular health management. CONNEQT Health operates across major global healthcare markets, delivering clinical-grade diagnostics, decentralized monitoring tools, and integrated digital health solutions.

The company’s operational foundation is built on its proprietary SphygmoCor vascular biometric technology, which noninvasively captures central aortic blood pressures, arterial stiffness indices, and central hemodynamics. CONNEQT Health manufactures and supplies medical diagnostic devices, digital health platforms, home care equipment, and wearable tools deployed in remote patient monitoring and decentralized clinical trials. Its global operational footprint encompasses research, sales, and distribution channels spanning the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.

CONNEQT Health holds a specialized market position by bridging professional cardiovascular diagnostics with scalable home health applications. The company sells its proprietary hardware and software solutions to hospitals, specialty clinics, pharmaceutical research institutions, and health-conscious consumers. Its ongoing strategic growth focus relies on expanding its connected health ecosystem, pursuing regulatory clearances, and driving commercial adoption of home-use diagnostic technologies to address the expanding global burden of hypertension and arterial disease.